|
1
|
Schütte K, Bornschein J and Malfertheiner
P: Hepatocellular carcinoma-epidemiological trends and risk
factors. Dig Dis. 27:80–92. 2009. View Article : Google Scholar
|
|
2
|
Abrams P and Marsh JW: Current approach to
hepatocellular carcinoma. Surg Clin North Am. 90:803–816. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin CL and Kao JH: Optimal management of
hepatocellular carcinoma: Challenges and opportunities. J
Gastroenterol Hepatol. 25:1336–1338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cano A, Santamaría PG and Moreno-Bueno G:
LOXL2 in epithelial cell plasticity and tumor progression. Future
Oncol. 8:1095–1108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akiri G, Sabo E, Dafni H, Vadasz Z,
Kartvelishvily Y, Gan N, Kessler O, Cohen T, Resnick M, Neeman M
and Neufeld G: Lysyl oxidase-related protein-1 promotes tumor
fibrosis and tumor progression in vivo. Cancer Res. 63:1657–1666.
2003.PubMed/NCBI
|
|
6
|
Payne SL, Hendrix MJ and Kirschmann DA:
Paradoxical roles for lysyl oxidases in cancer-a prospect. J Cell
Biochem. 101:1338–1354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hayashi K, Fong KS, Mercier F, Boyd CD,
Csiszar K and Hayashi M: Comparative immunocytochemical
localization of lysyl oxidase (LOX) and the lysyl oxidase-like
(LOXL) proteins: Changes in the expression of LOXL during
development and growth of mouse tissues. J Mol Histol. 35:845–855.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peinado H, Moreno-Bueno G, Hardisson D,
Pérez-Gómez E, Santos V, Mendiola M, de Diego JI, Nistal M,
Quintanilla M, Portillo F and Cano A: Lysyl oxidase-like 2 as a new
poor prognosis marker of squamous cell carcinomas. Cancer Res.
68:4541–4550. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li TY, Xu LY, Wu ZY, Liao LD, Shen JH, Xu
XE, Du ZP, Zhao Q and Li EM: Reduced nuclear and ectopic
cytoplasmic expression of lysyl oxidase-like 2 is associated with
lymph node metastasis and poor prognosis in esophageal squamous
cell carcinoma. Hum Pathol. 43:1068–1076. 2012. View Article : Google Scholar
|
|
10
|
Macartney-Coxson DP, Hood KA, Shi HJ, Ward
T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS and
Rooker S: Metastaticsusceptibility locus, an 8p hot-spot for tumour
progression disrupted in colorectal liver metastases: 13 candidate
genes examined at the DNA, mRNA and protein level. BMC Cancer.
8:1872008. View Article : Google Scholar
|
|
11
|
Offenberg H, Brünner N, Mansilla F,
Orntoft Torben F and Birkenkamp-Demtroder K: TIMP-1 expression in
human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1,
TNF-AIP6 and TIMP-2 transcript profiles. Mol Oncol. 2:233–240.
2008. View Article : Google Scholar
|
|
12
|
Peng L, Ran YL, Hu H, Yu L, Liu Q, Zhou Z,
Sun YM, Sun LC, Pan J, Sun LX, et al: Secreted LOXL2 is a novel
therapeutic target that promotes gastric cancer metastasis via the
Src/FAK pathway. Carcinogenesis. 30:1660–1669. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sano M, Aoyagi K, Takahashi H, Kawamura T,
Mabuchi T, Igaki H, Tachimori Y, Kato H, Ochiai A, Honda H, et al:
Forkhead box A1 transcriptional pathway in KRT7-expressing
esophageal squamous cell carcinomas with extensive lymph node
metastasis. Int J Oncol. 36:321–330. 2010.PubMed/NCBI
|
|
14
|
Brekhman V and Neufeld G: A novel
asymmetric 3D in-vitro assay for the study of tumor cell invasion.
BMC Cancer. 9:4152009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong CC, Tse AP, Huang YP, Zhu YT, Chiu
DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, et al: Lysyl
oxidase-like 2 is critical to tumor microenvironment and metastatic
niche formation in hepatocellular carcinoma. Hepatology.
60:1645–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferrandon S, Saultier P, Carras J,
Battiston-Montagne P, Alphonse G, Beuve M, Malleval C, Honnorat J,
Slatter T, Hung N, et al: Telomere profiling: Toward glioblastoma
personalized medicine. Mol Neurobiol. 47:64–76. 2013. View Article : Google Scholar
|
|
17
|
Hahn WC, Dessain SK, Brooks MW, King JE,
Elenbaas B, Sabatini DM, DeCaprio JA and Weinberg RA: Enumeration
of the simian virus 40 early region elements necessary for human
cell transformation. Mol Cell Biol. 22:2111–2123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song S, Zhou J, He S, Zhu D, Zhang Z, Zhao
H, Wang Y and Li D: Expression levels of microRNA-375 in pancreatic
cancer. Biomed Rep. 1:393–398. 2013.
|
|
19
|
Zheng Y, Wang DD, Wang W, Pan K, Huang CY,
Li YF, Wang QJ, Yuan SQ, Jiang SS, Qiu HB, et al: Reduced
expression of uroplakin 1A is associated with the poor prognosis of
gastric adenocarcinoma patients. PLoS One. 9:e930732014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li TY, Xu LY, Wu ZY, Liao LD, Shen JH, Xu
XE, Du ZP, Zhao Q and Li EM: Reduced nuclear and ectopic
cytoplasmic expression of lysyl oxidase-like 2 is associated with
lymph node metastasis and poor prognosis in esophageal squamous
cell carcinoma. Hum Pathol. 43:1068–1076. 2012. View Article : Google Scholar
|
|
21
|
Erler JT, Bennewith KL, Nicolau M,
Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS and Giaccia AJ:
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature.
440:1222–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barry-Hamilton V, Spangler R, Marshall D,
McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien
H, Wai C, et al: Allosteric inhibition of lysyl oxidase-like-2
impedes the development of a pathologic microenvironment. Nat Med.
16:1009–1017. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barker HE, Chang J, Cox TR, Lang G, Bird
D, Nicolau M, Evans HR, Gartland A and Erler JT: LOXL2-mediated
matrix remodeling in metastasis and mammary gland involution.
Cancer Res. 71:1561–1572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barker HE, Cox TR and Erler JT: The
rationale for targeting the LOX family in cancer. Nat Rev Cancer.
12:540–552. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peinado H, Del Carmen Iglesias-de la Cruz
M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A and
Portillo F: A molecular role for lysyl oxidase-like 2 enzyme in
snail regulation and tumor progression. EMBO J. 24:3446–3458. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhowmick NA, Neilson EG and Moses HL:
Stromal fibroblasts in cancer initiation and progression. Nature.
432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mahadevan D and Von Hoff DD: Tumor-stroma
interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther.
6:1186–1197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Radisky D, Hagios C and Bissell MJ: Tumors
are unique organs defined by abnormal signaling and context. Semin
Cancer Biol. 11:87–95. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tlsty TD and Coussens LM: Tumor stroma and
regulation of cancer development. Annu Rev Pathol. 1:119–150. 2006.
View Article : Google Scholar
|
